1. Home
  2. HRMY vs BKD Comparison

HRMY vs BKD Comparison

Compare HRMY & BKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$41.14

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Brookdale Senior Living Inc.

BKD

Brookdale Senior Living Inc.

HOLD

Current Price

$11.03

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
BKD
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
HRMY
BKD
Price
$41.14
$11.03
Analyst Decision
Buy
Buy
Analyst Count
9
5
Target Price
★ $44.11
$15.10
AVG Volume (30 Days)
849.5K
★ 3.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 7.97
N/A
EPS
★ 1.84
0.07
Revenue
$868,453,000.00
★ $4,531,426,000.00
Revenue This Year
$19.75
N/A
Revenue Next Year
$12.88
$4.30
P/E Ratio
★ $22.37
$158.14
Revenue Growth
★ 21.51
N/A
52 Week Low
$25.52
$7.97
52 Week High
$43.49
$17.09

Technical Indicators

Market Signals
Indicator
HRMY
BKD
Relative Strength Index (RSI) 52.86 26.62
Support Level $40.92 $10.71
Resistance Level $43.38 $11.17
Average True Range (ATR) 1.21 0.35
MACD -0.27 -0.01
Stochastic Oscillator 40.51 11.75

Price Performance

Historical Comparison
HRMY
BKD

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Share on Social Networks: